Related Experiment Video
Updated: Feb 8, 2026
06:59
Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
11.1K
Transcatheter aortic valve implantation in Germany
Won-Keun Kim1,2, Christian W Hamm3,4
1Department of Cardiology, Kerckhoff Heart Center, 61231, Bad Nauheim, Germany.
Summary
Transcatheter aortic valve implantation (TAVI) has evolved significantly, becoming a preferred treatment for severe aortic stenosis, especially in elderly patients. German contributions have been pivotal in advancing TAVI through pioneering achievements and clinical practice integration.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Device Technology
Background:
- Transcatheter aortic valve implantation (TAVI) has evolved from a novel procedure to a mature, integral treatment for severe aortic stenosis.
- Significant reductions in peri-procedural complications and mortality have established TAVI as a preferred therapy, particularly for elderly patients with high or prohibitive surgical risk.
Purpose of the Study:
- To highlight the significant contributions of Germany to the advancement of transcatheter aortic valve implantation (TAVI) technology and clinical practice.
- To showcase German pioneering achievements in TAVI, including early adoption, clinical trials, and procedural innovations.
Main Methods:
- Review of German involvement in first-in-man TAVI experiences.
- Analysis of participation in pivotal CE mark trials and randomized studies for TAVI devices.
- Examination of contributions to large TAVI registries and procedurally relevant aspects.
Main Results:
- Germany has been a leading nation in TAVI procedures and pioneering advancements.
- German involvement has been crucial in multiple phases of TAVI development, from initial trials to widespread clinical adoption.
- Pioneering German contributions have demonstrably impacted global TAVI clinical practice.
Conclusions:
- Germany has played a forefront role in the global evolution and adoption of TAVI.
- The collective efforts, including German innovations, have transformed TAVI into a standard treatment for severe aortic stenosis.
- Continued German engagement is vital for the future development and refinement of TAVI procedures.
Related Concept Videos
01:16Heart Valves
12.2K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
12.2K
01:27Mitral Valve Prolapse I: Introduction
570
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
570
01:15Aortic Regurgitation I: Introduction
657
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
657
01:22Mitral Valve Prolapse II: Assessment and Management
630
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
630
01:19Mitral Valve Prolapse III: Nursing Management
395
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
395
01:25Aortic Regurgitation III: Medical Management
461
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
461